James E. Besser, 10% Owner at FENNEC PHARMACEUTICALS INC. (FENC), bought 72,300 shares at $2.23 ($179K) on 2014-12-24, disclosed to the SEC on 2018-03-29.
Open-market purchase of $179k FENC by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.23 | 6,200 | $14K | 7.7% |
| 2 | $2.47 | 600 | $1K | 0.8% |
| 3 | $2.41 | 10,000 | $24K | 13.5% |
| 4 | $2.43 | 6,400 | $16K | 8.7% |
| 5 | $2.58 | 8,500 | $22K | 12.3% |
| 6 | $2.52 | 100 |
| $252 |
| 0.1% |
| 7 | $2.62 | 500 | $1K | 0.7% |
| 8 | $2.54 | 1,000 | $3K | 1.4% |
| 9 | $2.59 | 18,000 | $47K | 26.1% |
| 10 | $2.50 | 5,000 | $13K | 7.0% |
| 11 | $2.61 | 2,000 | $5K | 2.9% |
| 12 | $2.44 | 5,000 | $12K | 6.8% |
| 13 | $2.33 | 3,000 | $7K | 3.9% |
| 14 | $2.35 | 6,000 | $14K | 7.9% |
| Total | $2.47 avg | 72,300 | $179K | 100% |
| Filing → |
| PCSA | SELL | 2021-02-22 | $574K | — | Filing → |
| PCSA | BUY | 2020-10-13 | $121K | — | Filing → |
| MFST | BUY | 2019-05-02 | $7K | — | Filing → |